Andreas Wallnoefer
Direttore/Membro del Consiglio presso Eyebiotech Ltd.
Posizioni attive di Andreas Wallnoefer
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Eyebiotech Ltd.
 Eyebiotech Ltd. BiotechnologyHealth Technology Eyebiotech Ltd. is a British clinical stage ophthalmology company that treats patients with sight-threatening diseases. The company is based in London, UK. Eyebiotech was founded in 2021 by David R. Guyer and Anthony P. Adamis. David R. Guyer has been the CEO since 2021. | Direttore/Membro del Consiglio | - | - |
Jeito Capital SASU
 Jeito Capital SASU Investment ManagersFinance Jeito Capital SASU (Jeito Capital) is an Independent Venture Capital firm founded in 2018 by Rafaele Tordjman and headquartered in Paris, France. | Investitore di Private Equity | 01/10/2021 | - |
Storia della carriera di Andreas Wallnoefer
Statistiche
Distribuzione geografica
| Regno Unito | 2 |
| Francia | 2 |
Posizioni
| Director/Board Member | 1 |
| Private Equity Investor | 1 |
Settori
| Health Technology | 2 |
| Finance | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 2 |
|---|---|
Eyebiotech Ltd.
Eyebiotech Ltd. BiotechnologyHealth Technology Eyebiotech Ltd. is a British clinical stage ophthalmology company that treats patients with sight-threatening diseases. The company is based in London, UK. Eyebiotech was founded in 2021 by David R. Guyer and Anthony P. Adamis. David R. Guyer has been the CEO since 2021. | Health Technology |
Jeito Capital SASU
Jeito Capital SASU Investment ManagersFinance Jeito Capital SASU (Jeito Capital) is an Independent Venture Capital firm founded in 2018 by Rafaele Tordjman and headquartered in Paris, France. | Finance |
- Borsa valori
- Insiders
- Andreas Wallnoefer
- Esperienza
